NASDAQ:ARCT

Arcturus Therapeutics Holdings Stock Dividends

Healthcare > Biotechnology

Buy ARCT

*Your capital is at risk

$7.60

-0.0500 (-0.654%)

At Close: Jun 03, 2026

ARCT Dividends Insights

ARCT used to pay dividends monthly. Last paid amount was $0.0596 at Jan 15, 2013. As of today, dividend yield (TTM) is 0%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score
Start 7-Day Free Trial

AI Analysis of ARCT

AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.

AI Analysis of ARCT

AI-Powered Market Insights

New!

Dividend Analysis

Key Stats

Dividend Yield (TTM)	0%
Frequency	Monthly
1Y Growth	0%
Payout Ratio	0
Amount Per Share	$0.0596
Arcturus Therapeutics Holdings Inc. has not yet announced its next dividend date. Last payment date was: Jan 15, 2013.

ARCT Dividend Payout History

To ensure a understanding of ARCT's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.

#	Declaration Date	Ex-Date	Pay Date	Amount	Yield
1	Dec 27, 2012	Jan 08, 2013	Jan 15, 2013	$0.0596	0%
2	Dec 28, 2012	Jan 04, 2013	Jan 15, 2013	$0.0596	0%
3	Nov 28, 2012	Dec 05, 2012	Dec 15, 2012	$0.0600	0%
4	Oct 26, 2012	Nov 06, 2012	Nov 15, 2012	$0.0600	0%
5	Sep 27, 2012	Oct 03, 2012	Oct 15, 2012	$0.0600	0%
6	Aug 01, 2012	Sep 05, 2012	Sep 15, 2012	$0.0600	0%
7	Jul 26, 2012	Aug 06, 2012	Aug 15, 2012	$0.0600	0%
8	Jun 27, 2012	Jul 03, 2012	Jul 15, 2012	$0.0600	0%
9	May 29, 2012	Jun 06, 2012	Jun 15, 2012	$0.0600	0%
10	Apr 27, 2012	May 04, 2012	May 15, 2012	$0.0600	0%

Requires Login

Dividend Sustainability

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Overall, the near-term dividend outlook remains unpromising.

DSS - Sustainability score

Low (50.00%)

DSGP - Growth potential

No dividend growth expected in the near future

ARCT Stock Competitors

Symbol	Company Name	Market Cap	Amount Per Share	Dividend Yield (TTM)	Payout Ratio (TTM)
HSTM	HealthStream	716.941M	$0.0350	0.538%	19.15%
ARCT	Arcturus Therapeutics Holdings Inc.	216.015M	$0.0596	0%	-

FAQ

What factors can affect the amount of ARCT's dividend payments?

The amount of ARCT's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in ARCT sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from ARCT stock be automatically reinvested?

If ARCT offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy ARCT stock.

How often does ARCT pay dividend?

Arcturus Therapeutics Holdings Inc. (ARCT) used to pay dividends monthly. The most recent payout was on Jan 15, 2013.

How much does ARCT pays per share?

The last recorder (Jan 08, 2013) dividend per share was $0.0596.

What is ARCT dividend growth rate?

Over the last year, Arcturus Therapeutics Holdings Inc. has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 0%. Furthermore, examining the past 5 years, Arcturus Therapeutics Holdings Inc. has maintained an average Dividends Per Share Growth Rate of 0%.

ABOUT ARCTURUS THERAPEUTICS HOLDINGS INC.

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as we...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by